Skip to main content

Amyloid Cardiomyopathy clinical trials at UCSF
1 in progress, 0 open to new patients

  • Open-Label Study of AG10 in Patients With Cardiomyopathy

    Sorry, accepting new patients by invitation only

    This prospective, multicenter open-label study will evaluate the long-term safety, tolerability, PK and PD of AG10 administered on a background of stable heart failure therapy.

    San Francisco, California and other locations